Activity and Resistance of a Brain-Permeable Paradox Breaker BRAF Inhibitor in Melanoma Brain Metastasis
Ester Bonfill‐Teixidor(Vall d'Hebron Institut de Recerca), Joan Seoane(Institució Catalana de Recerca i Estudis Avançats)
Cited by 10
Related Papers
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours
|Annals of Oncology|2021|577
LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy
|Nature Communications|2019|258
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
|Journal of Clinical Investigation|2018|108